TGaS Advisory Brief
Home / Intelligence / Briefs / How to Lead and Develop High-Performing Field Matrix Teams
Many life sciences companies design customer engagement models that rely on coordination and communication between Account Managers, Sales, Reimbursement, Patient Services, and Field Medical to drive outcomes, performance, continuity and improve the customer and patient experience. These collaborative field teams are often formally or informally referred to as matrix or matrix-based field teams, and tend to be organized by Integrated Delivery Networks (IDNs), ecosystems and/or geography.
Executive stakeholders from Field Leadership, Brands and Market Access functions have shared during benchmark interviews that operating more effectively as matrix teams is a critical success factor. The challenges and complexities of operating as a high-performing matrix team seem easier to articulate than the capabilities and competencies needed to succeed. Common challenges include separate field-based roles engaging with the same customer and site of care too frequently, too close together; fears of compliance violations; conflicts within matrix teams around roles, responsibilities and swim lanes; unclear or inconsistent direction and accountability; and misaligned incentives.
In fact, searching online for “field matrix teams” in life sciences industry results in pages of job postings all requiring experience leading or managing field matrix teams, though no articles or resources on the topic are included.
(Go ahead, try it.)
Clearly, leading and developing high-performing field matrix teams is a coveted skillset, but much less clear is what success looks like, how to achieve it, and who will lead the organizational change from current to future-state.
To assist leaders in life science organizations to accelerate progress, TGaS Advisors identified:
- ROLES considered part of field matrix teams
- CAPABILITIES of high-performing field matrix teams
- Specific role-based SKILLS and COMPETENCIES necessary to improve performance of field matrix teams
In September of 2022, TGaS Advisors sent an electronic survey to L&D professionals within life science companies. Surveys were completed by 21 individuals from 18 unique companies. Twelve companies (67%) were mid/large tier, and six (33%) represent emerging/small tier companies.
Complete the form below to access the full brief and view the results
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Briefs
2025 Annual State of Learning & Development in Life Sciences
Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant. For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, […]
Read More
Briefs
Leading the Evolution: Navigating AI and Pharma Market Trends
How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit.
Read More
Blog
Is Medical Omnichannel Poised for Growth?
79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel. What […]
Read More